Ball Bearings From Japan and the United Kingdom, 798-799 [2010-33355]

Download as PDF 798 Federal Register / Vol. 76, No. 4 / Thursday, January 6, 2011 / Notices treatment. All such requests should be directed to the Secretary to the Commission and must include a full statement of the reasons why the Commission should grant such treatment. See 19 CFR 201.6. Documents for which confidential treatment by the Commission is properly sought will be treated accordingly. All nonconfidential written submissions will be available for public inspection at the Office of the Secretary. This action is taken under the authority of section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and of sections 201.10 and 210.50(a)(4) of the Commission’s Rules of Practice and Procedure (19 CFR 201.10, 210.50(a)(4)). Issued: December 30, 2010. By order of the Commission. Marilyn R. Abbott, Secretary to the Commission. [FR Doc. 2010–33356 Filed 1–5–11; 8:45 am] BILLING CODE 7020–02–P INTERNATIONAL TRADE COMMISSION [Investigation Nos. 731–TA–394–A & 399– A (Second Review) (Fourth Remand)] Ball Bearings From Japan and the United Kingdom United States International Trade Commission. ACTION: Notice of remand proceedings. AGENCY: The U.S. International Trade Commission (‘‘Commission’’) hereby gives notice of its fourth remand proceeding with respect to its affirmative determination in the fiveyear review of the antidumping duty order on ball bearings from Japan. For further information concerning the conduct of this proceeding and rules of general application, consult the Commission’s Rules of Practice and Procedure, part 201, subparts A through E (19 CFR part 201), and part 207, subpart A (19 CFR part 207). DATES: Effective Date: December 30, 2010. FOR FURTHER INFORMATION CONTACT: James McClure, Office of Investigations, telephone 202–205–3191, or David Goldfine, Office of General Counsel, telephone 202–708–5452, U.S. International Trade Commission, 500 E Street, SW., Washington, DC 20436. Hearing-impaired persons can obtain information on this matter by contacting the Commission’s TDD terminal on 202– 205–1810. Persons with mobility impairments who will need special assistance in gaining access to the erowe on DSK5CLS3C1PROD with NOTICES SUMMARY: VerDate Mar<15>2010 15:07 Jan 05, 2011 Jkt 223001 Commission should contact the Office of the Secretary at 202–205–2000. General information concerning the Commission may also be obtained by accessing its Internet server (http:// www.usitc.gov). SUPPLEMENTARY INFORMATION: Background.—On December 9, 2010, the Court of International Trade (per Judge Barzilay) issued an opinion in NSK Corp. et al. v. United States, Slip Op. 10–133 (‘‘NSK V’’). In that opinion, the Court has again affirmed-in-part and remanded-in-part the Commission’s determinations in Certain Bearings and Parts Thereof from Japan and the United Kingdom, Inv. Nos. 731–TA– 394–A & 399–A (Second Review) (Third Remand), USITC Pub. 4194 (Aug. 2010). In NSK V, the Court affirmed the Commission’s determination not to cumulate subject imports from the United Kingdom because they would not likely have a discernible adverse impact. NSK V at 4–6. The Court also affirmed the Commission’s negative determination with respect to the United Kingdom. Id. at 6. As to the remaining issues with respect to the cumulated subject imports from France, Germany, Italy, and Japan, the Court again affirmed the Commission’s findings that the cumulated imports would likely have significant volume and price effects. Id. at 7. Nevertheless, with respect to the likely impact by cumulated subject imports, the Court again remanded the issue to the Commission. Id. at 8–12. Under the remand schedule ordered by the Court, the Commission was required to file a status report with the Court on December 20, 2010, advising the Court as to whether it would be reopening the record on the likely impact issue. The Court also directed the parties to submit a proposed joint scheduling order for the fourth remand proceedings. On December 20, 2010, the Commission filed the requested status report with the Court, advising the Court that it will not be re-opening the record. On December 20, 2010, the parties also submitted a proposed joint scheduling order. On December 22, 2010, the Court approved the proposed scheduling order and directed the Commission to file its fourth remand determination by March 1, 2011. Under the remand schedule ordered by the Court, Plaintiffs, Plaintiff-Intervenors, and Defendant-Intervenors may file their comments with the Court regarding the Commission’s fourth remand determination by April 1, 2011. Participation in the proceeding.— Only those persons who were interested PO 00000 Frm 00029 Fmt 4703 Sfmt 4703 parties to the reviews (i.e., persons listed on the Commission Secretary’s service list) and parties to the appeal may participate in the remand proceeding. Such persons need not make any additional filings with the Commission to participate in the remand proceeding, unless they are adding new individuals to the list of persons entitled to receive business proprietary information under administrative protective order. Business proprietary information (‘‘BPI’’) referred to during the remand proceeding will be governed, as appropriate, by the administrative protective order issued in the reviews. Written submissions.—The Commission is not re-opening the record in this remand proceeding. The Commission will permit the parties to file comments pertaining to the specific issues that are the subject of the Court’s remand instructions. Comments should be limited to no more than fifteen (15) double-spaced and single-sided pages of textual material. No appendices or other attachments are allowed. The parties may not themselves submit any new factual information in their comments and may not address any issue other than those that are the subject of the Court’s remand instructions. Any such comments must be filed with the Commission no later than January 14, 2011. All written submissions must conform with the provisions of section 201.8 of the Commission’s rules; any submissions that contain BPI must also conform with the requirements of sections 201.6, 207.3, and 207.7 of the Commission’s rules. The Commission’s rules do not authorize filing of submissions with the Secretary by facsimile or electronic means, except to the extent permitted by section 201.8 of the Commission’s rules, as amended, 67 Fed. Reg. 68036 (Nov. 8, 2002). In accordance with sections 201.16(c) and 207.3 of the Commission’s rules, each document filed by a party to the investigation must be served on all other parties to the investigation (as identified by either the public or BPI service list), and a certificate of service must be timely filed. The Secretary will not accept a document for filing without a certificate of service. Parties are also advised to consult with the Commission’s Rules of Practice and Procedure, part 201, subparts A through E (19 CFR part 201), and part 207, subpart A (19 CFR part 207) for provisions of general applicability concerning written submissions to the Commission. By order of the Commission. E:\FR\FM\06JAN1.SGM 06JAN1 Federal Register / Vol. 76, No. 4 / Thursday, January 6, 2011 / Notices Issued: December 30, 2010. Marilyn R. Abbott, Secretary to the Commission. Drug Sufentanil (9740) .......................... [FR Doc. 2010–33355 Filed 1–5–11; 8:45 am] BILLING CODE 7020–02–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Registration By Notice dated June 17, 2010, and published in the Federal Register on June 28, 2010, 75 FR 36680, United States Pharmacopeial Convention, 12601 Twinbrook Parkway, Rockville, Maryland 20852, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the following basic classes of controlled substances: Drug Schedule Cathinone (1235) .......................... Methaqualone (2565) ................... Lysergic acid diethylamide (7315) Marihuana (7360) ......................... Tetrahydrocannabinols (7370) ..... 4-Methyl-2,5dimethoxyamphetamine (7395). 3,4-Methylenedioxyamphetamine (7400). Codeine-n-oxide (9053) ................ Heroin (9200) ............................... Amphetamine (1100) .................... Drug erowe on DSK5CLS3C1PROD with NOTICES I The company plans to import reference standards for sale to researchers and analytical labs. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) and determined that the registration of United States Pharmacopeial Convention to import the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. DEA has investigated United States Pharmacopeial Convention to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic classes of controlled substances listed. Dated: December 23, 2010. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. I I II Dated: December 23, 2010. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2011–11 Filed 1–5–11; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF LABOR [FR Doc. 2011–12 Filed 1–5–11; 8:45 am] II II II II II II II II II II II II II II II II II II II II II BILLING CODE 4410–09–P Employee Benefits Security Administration DEPARTMENT OF JUSTICE Publication of Year 2010 Form M–1 With Electronic Filing Option, Notice Drug Enforcement Administration Morphine (9300) ........................... Thebaine (9333) ........................... Oxymorphone (9652) ................... Noroxymorphone (9668) .............. Alfentanil (9737) ........................... By Notice dated October 15, 2010, and published in the Federal Register on October 26, 2010, 75 FR 65660, Noramco Inc., 1440 Olympic Drive, Athens, Georgia 30601, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the following basic classes of controlled substances: Drug Schedule Thebaine (9333) ......................... Tapentadol (9780) ...................... II II II II II The company plans to import Thebaine (9333) analytical reference standards for distribution to its customers. The company plans to Jkt 223001 Employee Benefits Security Administration, Department of Labor. ACTION: Notice on the Availability of the Year 2010 Form M–1 with Electronic Filing Option. AGENCY: Importer of Controlled Substances; Notice of Registration Schedule Drug 15:07 Jan 05, 2011 I I I I I I II import an intermediate form of Tapentadol (9780) to bulk manufacture Tapentadol for distribution to its customers. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) and determined that the registration of Noramco Inc. to import the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. DEA has investigated Noramco Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic classes of controlled substances listed. Schedule Methamphetamine (1105) ............ Phenmetrazine (1631) .................. Methylphenidate (1724) ................ Amobarbital (2125) ....................... Pentobarbital (2270) ..................... Secobarbital (2315) ...................... Glutethimide (2550) ...................... Phencyclidine (7471) .................... Alphaprodine (9010) ..................... Anileridine (9020) ......................... Cocaine (9041) ............................. Codeine (9050) ............................. Dihydrocodeine (9120) ................. Oxycodone (9143) ........................ Hydromorphone (9150) ................ Diphenoxylate (9170) ................... Hydrocodone (9193) ..................... Levorphanol (9220) ...................... Meperidine (9230) ........................ Methadone (9250) ........................ Dextropropoxyphene, bulk (nondosage forms) (9273). VerDate Mar<15>2010 Schedule 799 PO 00000 Frm 00030 Fmt 4703 Sfmt 4703 II II This document announces the availability of the Year 2010 Form M– 1, Annual Report for Multiple Employer Welfare Arrangements and Certain Entities Claiming Exception. It is generally identical to the 2009 Form M– 1, except that a few changes were made to update the Part 7 compliance questions to reflect the current provisions of Part 7 that were effective in 2010. The Form M–1 may again be filed electronically over the Internet. FOR FURTHER INFORMATION CONTACT: For inquiries regarding the Form M–1 filing requirement, contact Amy J. Turner or Beth L. Baum, Office of Health Plan Standards and Compliance Assistance, SUMMARY: E:\FR\FM\06JAN1.SGM 06JAN1

Agencies

[Federal Register Volume 76, Number 4 (Thursday, January 6, 2011)]
[Notices]
[Pages 798-799]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-33355]


-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[Investigation Nos. 731-TA-394-A & 399-A (Second Review) (Fourth 
Remand)]


Ball Bearings From Japan and the United Kingdom

AGENCY: United States International Trade Commission.

ACTION: Notice of remand proceedings.

-----------------------------------------------------------------------

SUMMARY: The U.S. International Trade Commission (``Commission'') 
hereby gives notice of its fourth remand proceeding with respect to its 
affirmative determination in the five-year review of the antidumping 
duty order on ball bearings from Japan. For further information 
concerning the conduct of this proceeding and rules of general 
application, consult the Commission's Rules of Practice and Procedure, 
part 201, subparts A through E (19 CFR part 201), and part 207, subpart 
A (19 CFR part 207).

DATES: Effective Date: December 30, 2010.

FOR FURTHER INFORMATION CONTACT: James McClure, Office of 
Investigations, telephone 202-205-3191, or David Goldfine, Office of 
General Counsel, telephone 202-708-5452, U.S. International Trade 
Commission, 500 E Street, SW., Washington, DC 20436. Hearing-impaired 
persons can obtain information on this matter by contacting the 
Commission's TDD terminal on 202-205-1810. Persons with mobility 
impairments who will need special assistance in gaining access to the 
Commission should contact the Office of the Secretary at 202-205-2000. 
General information concerning the Commission may also be obtained by 
accessing its Internet server (http://www.usitc.gov).

SUPPLEMENTARY INFORMATION: 
    Background.--On December 9, 2010, the Court of International Trade 
(per Judge Barzilay) issued an opinion in NSK Corp. et al. v. United 
States, Slip Op. 10-133 (``NSK V''). In that opinion, the Court has 
again affirmed-in-part and remanded-in-part the Commission's 
determinations in Certain Bearings and Parts Thereof from Japan and the 
United Kingdom, Inv. Nos. 731-TA-394-A & 399-A (Second Review) (Third 
Remand), USITC Pub. 4194 (Aug. 2010). In NSK V, the Court affirmed the 
Commission's determination not to cumulate subject imports from the 
United Kingdom because they would not likely have a discernible adverse 
impact. NSK V at 4-6. The Court also affirmed the Commission's negative 
determination with respect to the United Kingdom. Id. at 6.
    As to the remaining issues with respect to the cumulated subject 
imports from France, Germany, Italy, and Japan, the Court again 
affirmed the Commission's findings that the cumulated imports would 
likely have significant volume and price effects. Id. at 7. 
Nevertheless, with respect to the likely impact by cumulated subject 
imports, the Court again remanded the issue to the Commission. Id. at 
8-12.
    Under the remand schedule ordered by the Court, the Commission was 
required to file a status report with the Court on December 20, 2010, 
advising the Court as to whether it would be re-opening the record on 
the likely impact issue. The Court also directed the parties to submit 
a proposed joint scheduling order for the fourth remand proceedings.
    On December 20, 2010, the Commission filed the requested status 
report with the Court, advising the Court that it will not be re-
opening the record. On December 20, 2010, the parties also submitted a 
proposed joint scheduling order. On December 22, 2010, the Court 
approved the proposed scheduling order and directed the Commission to 
file its fourth remand determination by March 1, 2011. Under the remand 
schedule ordered by the Court, Plaintiffs, Plaintiff-Intervenors, and 
Defendant-Intervenors may file their comments with the Court regarding 
the Commission's fourth remand determination by April 1, 2011.
    Participation in the proceeding.--Only those persons who were 
interested parties to the reviews (i.e., persons listed on the 
Commission Secretary's service list) and parties to the appeal may 
participate in the remand proceeding. Such persons need not make any 
additional filings with the Commission to participate in the remand 
proceeding, unless they are adding new individuals to the list of 
persons entitled to receive business proprietary information under 
administrative protective order. Business proprietary information 
(``BPI'') referred to during the remand proceeding will be governed, as 
appropriate, by the administrative protective order issued in the 
reviews.
    Written submissions.--The Commission is not re-opening the record 
in this remand proceeding. The Commission will permit the parties to 
file comments pertaining to the specific issues that are the subject of 
the Court's remand instructions. Comments should be limited to no more 
than fifteen (15) double-spaced and single-sided pages of textual 
material. No appendices or other attachments are allowed. The parties 
may not themselves submit any new factual information in their comments 
and may not address any issue other than those that are the subject of 
the Court's remand instructions. Any such comments must be filed with 
the Commission no later than January 14, 2011.
    All written submissions must conform with the provisions of section 
201.8 of the Commission's rules; any submissions that contain BPI must 
also conform with the requirements of sections 201.6, 207.3, and 207.7 
of the Commission's rules. The Commission's rules do not authorize 
filing of submissions with the Secretary by facsimile or electronic 
means, except to the extent permitted by section 201.8 of the 
Commission's rules, as amended, 67 Fed. Reg. 68036 (Nov. 8, 2002).
    In accordance with sections 201.16(c) and 207.3 of the Commission's 
rules, each document filed by a party to the investigation must be 
served on all other parties to the investigation (as identified by 
either the public or BPI service list), and a certificate of service 
must be timely filed. The Secretary will not accept a document for 
filing without a certificate of service.
    Parties are also advised to consult with the Commission's Rules of 
Practice and Procedure, part 201, subparts A through E (19 CFR part 
201), and part 207, subpart A (19 CFR part 207) for provisions of 
general applicability concerning written submissions to the Commission.

    By order of the Commission.


[[Page 799]]


    Issued: December 30, 2010.
Marilyn R. Abbott,
Secretary to the Commission.
[FR Doc. 2010-33355 Filed 1-5-11; 8:45 am]
BILLING CODE 7020-02-P